Join us on August 19th at 3 PM PT, when Dr. Christopher Shade, PhD, CEO and founder of Quicksilver Scientific, explains what makes a quality liposome and nanoemulsion and why this next generation technology is changing the way we look at nutraceutical supplementation delivery. Learn how nanoparticle formulations offer greater bioavailability, working on a cellular level thus supporting more consistent, therapeutic outcomes.
A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.
We hope you can join us live on August 19th at 3 PM PT. If not, don’t worry, signing up will still grant you access to the webinar recording.